NDC 68025-047-01 - Lorzone
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68025-047
- Requested NDC
- 68025-047-01
- Package NDCs from labels
- 68025-047-10, 68025-047-01, 68025-047-02
- Manufacturer
- Vertical Pharmaceuticals, Inc.
- Effective date
- 2023-09-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lorzone | Vertical Pharmaceuticals, Inc. | 2023-09-29 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68025-047-10 | EA - Each | 68025-047 | 7d8728a7-8b74-4dcd-b339-4d2b5abfe61f | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CHLORZOXAZONE | CHLORZOXAZONE | Camber Pharmaceuticals, Inc. | e9bb9ebf-fceb-4da8-950a-c4b1fd5a84f1 | 2025-03-16 | Warnings, Adverse reactions | H0DE420U8G |
| Addiclenz | ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYLPARABEN, PROPYLPARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM, ARSENICUM ALBUM, BETA VULGARIS, BISPHENOL A, BOLDO, CHELIDONIUM MAJUS, COBALTUM METALLICUM, CUPRUM METALLICUM, GLYPHOSATE, IODIUM, LYCOPODIUM CLAVATUM, PETROSELINUM SATIVUM, PHOSPHORICUM ACIDUM, SELENIUM METALLICUM, TARAXACUM OFFICINALE, ZINCUM METALLICUM | Deseret Biologicals, Inc. | 25036c26-1c21-4e5a-b4db-b8e177458341 | 2025-03-11 | Warnings | OJ245FE5EU |
| CHLORZOXAZONE | CHLORZOXAZONE | Proficient Rx LP | 0a8ee5fa-f393-4568-81bd-269f9a4cecd6 | 2025-03-01 | Warnings, Adverse reactions | H0DE420U8G |
| YVTYVT MICRODERMABRASION FACIAL SCRUB | YVTYVT MICRODERMABRASION FACIAL SCRUB | Beijing JUNGE Technology Co., Ltd. | 2f30fc45-42e2-c766-e063-6394a90a8d68 | 2025-02-28 | Warnings | OP1R32D61U |
| Se-Natal 19 | .BETA.-CAROTENE, ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, THIAMINE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, CYANOCOBALAMIN, CALCIUM PANTOTHENATE, CALCIUM CARBONATE, FERROUS FUMARATE, ZINC OXIDE AND DOCUSATE SODIUM | Seton Pharmaceuticals | 635104e6-6a53-4684-ac9a-7ac31b33083d | 2025-02-24 | Boxed warning, Warnings, Adverse reactions | F05Q2T2JA0 |
| SODIUM PHENYLACETATE and SODIUM BENZOATE | SODIUM PHENYLACETATE AND SODIUM BENZOATE | Omnivium Pharmaceuticals LLC | 9067c301-74f9-457a-9b0f-b7e9b06a3508 | 2025-02-15 | Warnings, Adverse reactions | OJ245FE5EU |
| Stool Softener and Stimulant Laxative | DOCUSATE SODIUM, SENNOSIDES | H-E-B | c19280c2-f968-b582-e053-2995a90a9bd3 | 2025-02-14 | Warnings | F05Q2T2JA0 |
| STOOL SOFTENER-STIMULANT LAXATIVE | STOOL SOFTENER-STIMULANT LAXATIVE | Kroger Company | a22c9f95-e3a9-bfd3-e053-2995a90a3c66 | 2025-02-13 | Warnings | F05Q2T2JA0 |
| SENNA-S | DOCUSATE SODIUM AND SENNOSIDES | KROGER | a187045c-c9d6-592a-e053-2995a90adb83 | 2025-02-10 | Warnings | F05Q2T2JA0 |
| SENNA TIME S | DOCUSATE SODIUM-SENNOSIDES | TIME CAP LABORATORIES, INC | dc491692-8d3a-4ccd-a17d-4c630f122595 | 2025-02-08 | Warnings | F05Q2T2JA0 |
| SENNOSIDES AND DOCUSATE SODIUM | SENNOSIDES AND DOCUSATE SODIUM | TIME CAP LABORATORIES, INC | 0ad617e0-10a6-44fa-be62-4f3cc725fb01 | 2025-02-08 | Warnings | F05Q2T2JA0 |
| Sennosides and Docusate Sodium | SENNOSIDES, DOCUSATE SODIUM | Asclemed USA, Inc. | 2db546de-20dc-4697-aff2-12471f073b1d | 2025-02-08 | Warnings | F05Q2T2JA0 |
| Docusate Sodium | DOCUSATE SODIUM | PAI Holdings, LLC dba PAI Pharma | e975a3f1-0e1f-4fb8-9c5f-baa75e12f2a5 | 2025-02-06 | Warnings | F05Q2T2JA0 |
| Docusate Sodium | DOCUSATE SODIUM | PD-Rx Pharmaceuticals, Inc. | 6a7e4193-22d2-491e-9842-5c43f571fc65 | 2025-02-05 | Warnings | F05Q2T2JA0 |
| DOCUSATE SODIUM 50MG SOFTGEL (RED) | DOCUSATE SODIUM | CVS Pharmacy | 273e5b52-1cf9-2525-e063-6394a90a8b4f | 2025-02-04 | Warnings | F05Q2T2JA0 |
| CHLORZOXAZONE | CHLORZOXAZONE | A-S Medication Solutions | d0210638-b828-4c05-9669-fd61ef987317 | 2025-02-04 | Warnings, Adverse reactions | H0DE420U8G |
| Stool Softener Laxative | DOCUSATE SODIUM | NuCare Pharmaceuticals, Inc. | 2c65319f-6cf5-aa90-e063-6394a90ad662 | 2025-01-23 | Warnings | F05Q2T2JA0 |
| Sennosides and Docusate Sodium | SENNOSIDES, DOCUSATE SODIUM | Reliable-1 Laboratories LLC | a97a1829-f62f-2014-e053-2a95a90a8cc5 | 2025-01-15 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | NCS HealthCare of KY, LLC dba Vangard Labs | 4d678da0-9ada-4d00-9db9-33b45c776107 | 2025-01-15 | Warnings | F05Q2T2JA0 |
| Senna-S | SENNOSIDES 8.6MG AND DOCUSATE SODIUM 50MG | Ulai Health LLC | c0e27b02-8ef2-4239-8f8c-790f7d978dc0 | 2025-01-12 | Warnings | F05Q2T2JA0 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.